Methanol Leaf Extract of Diospyros mespiliformis Hochst. offers Protection against Some Chemoconvulsants

Main Article Content

Kasimu Muhammad
Mohammed G. Magaji
Nuhu M. Danjuma
Abdulkadir U. Zezi
Samuel S. Gyang

Abstract

Diospyros mespiliformis Hochst (Ebenaceae) is reported to have wide ethnomedical application notably in the management of fever, whooping cough, wounds, pneumonia, syphilis, leprosy and epilepsy among others. This study examined the anticonvulsant activity of its methanol leaf extract at the doses of 50, 100 and 200 mg/kg in pentylenetetrazole, maximal electroshock, strychnine, picrotoxin and 4-aminopyridine induced seizure tests. The intraperitoneal and oral median lethal doses of the extract were estimated in mice, rats and chicks. The extract at doses of 50, 100 and 200 mg/kg protected the mice (50%, 66.67% and 66.67%, respectively) against pentylenetetrazole induced seizures. The extract at all doses tested did not offer protection against maximal electroshock and 4-amino pyridine induced seizures. The extract significantly prolonged the onset of seizure induced by strychnine. The extract protected 83.3% of the mice against picrotoxininduced seizure at the highest dose tested (200 mg/kg) and significantly (P < 0.05) increased the onset of seizure in the unprotected animals at the lower doses (50 and 100 mg/kg). The median lethal dose (LD50) values of D. mespiliformis methanol leaf extract was found to be 774.6 mg/kg i.p. and greater than 5000 mg/kg p.o. in both rats and mice. In chick, the LD50 was found to be >5000 mg/kg, intraperitoneally. These results suggest that D. mespiliformis leaf extract possesses anticonvulsant activity and provide some scientific justification for the ethnomedicinal use of the leaves of the plant in the management of epilepsy.

Downloads

Download data is not yet available.

Article Details

How to Cite
Muhammad, K., G. Magaji, M., M. Danjuma, N., U. Zezi, A., & S. Gyang, S. (2017). Methanol Leaf Extract of Diospyros mespiliformis Hochst. offers Protection against Some Chemoconvulsants. Tropical Journal of Natural Product Research (TJNPR), 1(3), 113-117. https://tjnpr.org/index.php/home/article/view/296
Section
Articles

How to Cite

Muhammad, K., G. Magaji, M., M. Danjuma, N., U. Zezi, A., & S. Gyang, S. (2017). Methanol Leaf Extract of Diospyros mespiliformis Hochst. offers Protection against Some Chemoconvulsants. Tropical Journal of Natural Product Research (TJNPR), 1(3), 113-117. https://tjnpr.org/index.php/home/article/view/296

References

World Health Organization. Traditional Medicine Fact sheet No. 134.

Olubunmi AO. Epilepsy in Nigeria–A review of etiology, epidemiology and management. Benin Journal of Postgraduate Medicine. 2006; 8(1).

McAuley, J.W. and Lott, R.S. (2008). Seizure Disorders. In: Applied Therapeutics. The clinical use of drugs. Edited by Mary

Anne Koda-Kimble et al 9th Edition. Lippincott Williams and Wilkins. Maryland USA Ch. 54. p. 1-33.

Browne TR, Holmes GL. Handbook of epilepsy. Jones & Bartlett Learning; 2008.

Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol. 2009; 8(11):1019-1030.

Shorvon SD. Epidemiology, classification, natural history, and genetics of epilepsy. The Lancet. 1990;336(8707):93-6.

Banerjee PN, Filippi D, Hauser WA. The descriptive epidemiology of epilepsy—a review. Epilepsy Res. 2009; 85(1):31-45.

Cascino GD. Epilepsy: contemporary perspectives on evaluation and treatment. In Mayo Clinic Proceedings 1994 Dec 31 (Vol. 69, No. 12, pp. 1199-1211). Elsevier.

Samren EB, Duijn CV, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, Mannagetta GB, Deichl AW, Gaily E, Granström IL, Meinardi H. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia. 1997; 38(9):981-990.

Ojewole JA. Evaluation of the analgesic, anti‐inflammatory and anti‐diabetic properties of Sclerocarya birrea (A. Rich.) Hochst. stem‐bark aqueous extract in mice and rats. Phytother Res. 2004;18(8):601-608.

Dalziel, 1937 Dalziel JM. The useful plants of tropical West Africa. Crown Agencies for the Colonies, London. 1937.

Watt JM, Breyer-Brandwijk MG. The Medicinal and Poisonous Plants of Southern and Eastern Africa being an Account of their

Medicinal and other Uses, Chemical Composition, Pharmacological Effects and Toxicology in Man and Animal. The Medicinal and Poisonous Plants of Southern and Eastern Africa being an Account of their Medicinal and other Uses, Chemical Composition, Pharmacological Effects and

Toxicology in Man and Animal.. 1962(Edn 2).

Burkill HM. The useful plants of west tropical Africa. Volume 2: Families EI. Royal Botanic Gardens; 1994.

Etkin NL. A Hausa herbal pharmacopoeia: biomedical evaluation of commonly used plant medicines. J Ethnopharmacol. 1981; 4(1):75-98.

Sofowora A. Medicinal plants and traditional medicine in Africa. 1982

Evans WC. Trease and Evans' pharmacognosy. Elsevier Health Sciences; 2009; 27.

Lorke D. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983; 54(4):275-287.

Swinyard, E.A., Woodhead, J.H., White, H.S. and Franklin, M.R. (1989). General Principles: Experimental selection,

quantification, and evaluation of anticonvulsants. In:Levy, R.H., Mattson, B., Melrum, J.K. and Dreifuss, F.E. (Eds) Antiepileptic Drugs, 3rd edition. Raven Press. New York. USA. pp. 85-103.

Toman JE, Swinyard EA, Goodman LS. Properties of maximal seizures, and their alteration by anticonvulsant drugs and other agents. J. Neurophysiol. 1946;9(3):231-239

Swinyard EA, Kupferberg HJ. Antiepileptic drugs: detection, quantification, and evaluation. Fed. Proc. 1985; 44(10):2629-

Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B, White BG. Antiepileptic drug development program. Cleve. Clin. Q. 1984; 51(2):293-305.

Ruíz AN, Ramírez BB, Estrada JG, López PG, Garzon P. Anticonvulsant activity of Casimiroa edulis in comparison to phenytoin and phenobarbital. J Ethnopharmacol. 1995; 45(3):199-206.

Yamaguchi SI, Rogawski MA. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res.

; 11(1):9-16.

Kumar GP, Khanum F. Neuroprotective potential of phytochemicals. Pharmacogn Rev. 2012;6(12):81.

Bammidi SR, Volluri SS, Chippada SC, Avanigadda S, Vangalapati M. A review on pharmacological studies of Bacopa monniera. J. chem. biol.

phys. sci. 2011;1(2):250.

Ribeiro RA, Leite JR. Nantenine alkaloid presents anticonvulsant effect on two classical animal models. Phytomedicine. 2003; 10(6-7):563-568.

Holtkamp M, Meierkord H. Biomedicine and Diseases: Review Anticonvulsant, antiepileptogenic and antiictogenic pharmacostrategies. Cell. Mol. Life Sci. 2007; 64:2023-2041.

Löscher W, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 1991; 8(2):79-94.

Löscher W. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. 1998; 342(1):1-3.

Rho JM, Sankar R. The pharmacologic basis of antiepileptic drug action. Epilepsia. 1999; 40(11):1471-1483.

De Deyn PP, D'Hooge R, Marescau B, Pei YQ. Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants. Epilepsy Res. 1992;12(2):87-110.

Thomsen C, Dalby NO. Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice. Neuropharmacol. 1998; 37(12):1465-1473.

White HS (1997). New Mechanisms for antiepileptic drugs II. In: Epilepsies. Porter, R and Chadwick, D (Eds). Butterworth Heinemann, Boston. 1997; p. 1-30.

White HS. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia. 2003;44(s7):2-8.

Mares P, Kubova H. Electrical stimulation induced model of seizures and Epilepsy. Pitkanen, A; Schwartzkroin, P.A; Moshe,

.L (Eds). Elsevier Academic Press. USA Chapter. 2006; 12: 153-159.

Holmes TR, Browne GL. Handbook of epilepsy (4th Ed.) Philadelphia: Lippincott Williams and Wilkins.2008

Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 1996;37(s6):S4-11.

Meldrum BS. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia. 1997;38(s9):S7-15.

Vogel H, editor. Drug discovery and evaluation: pharmacological assays. Springer Science & Business Media; 2007

Raza ML, Zeeshan M, Ahmad M, Shaheen F, Simjee SU. Anticonvulsant activity of DNS II fraction in the acute seizure models. J Ethnopharmacol. 2010;128(3):600-605.

Umukoro S, Omogbiya IA, Eduviere AT. Evaluation of the Effect of Jobelyn® on Chemoconvulsants-Induced Seizure in Mice. Basic Clin. Neurosci. 2013; 4(2): 125.

Rostock A, Tober C, Rundfeldt C, Bartsch R, Engel J, Polymeropoulos EE, Kutscher B, Löscher W, Hönack D, White HS, Wolf HH. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 1996; 23(3):211-223.

Wickenden AD. Potassium channels as anti-epileptic drug targets. Neuropharmacology 2002; 43(7):1055-1060